FMP
Financial data for every need
We provide one of the most accurate financial data available on the market. You can get historical prices, fundamental data, insider transactions, and much more that goes back 30 years in history.
Get started
70,000+ Stocks with tons of data
Ready to Unlock Insights?
Welcome to our comprehensive suite of tools designed to streamline your financial data integration process.
API Documentation
Access user-friendly RESTful API documentation suitable for all skill levels.
Detailed endpoint documentation.
Clear request/response examples.
Streamlined navigation.
Ensures clarity/reliability.
API Viewer
Explore endpoints hassle-free with our code-free API Playground.
Interactive data tools.
User-friendly interface.
Download data in CSV/Excel.
Ideal for hands-on exploration.
Stock Prices
Real-time Prices, Historical Data and Indicators.
Stock Fundamentals
Financial Statements, Key Metrics, Stock Financial Scores and more.
Market News
Stock News, Press Releases and Experts Articles.
Company Information
Company Outlook, Market Capitalization, Company Core Information.
Data is collected only from trusted sources
Quality data is key to making accurate, informed decisions. All our data is licensed and sourced from curated third-party data partners, such as the U.S. Securities and Exchange Commission (SEC), Board of Governors of the Federal Reserve System.
See DocumentationFast, accurate, and developer friendly
We provide one of the most accurate data available on the market. We spent years designing endpoints and made them informative, well-documented, and easy to use.
Our API has over 100 endpoints and we are still growing and adding new endpoints every week. Every endpoint is available in JSON format and most of them also in CSV format.
We also provide on demand custom endpoint available for our enterprise plan.
See documentation
Trusted by 100,000+ customers
Join us and get your API key
Latest News
Stay Updated and Harness the Power of Our API with the Latest News!
Jul 15, 2025 1:02 PM - Davit Kirakosyan
Wells Fargo Beats Earnings, But Weak Net Interest Income Weighs on Shares
Wells Fargo & Company (NYSE:WFC) reported stronger-than-expected second-quarter earnings and revenue, but a shortfall in net interest income (NII) tempered the market’s response, sending shares 5% lower intra-day today. The bank posted earnings of $1.60 per share, outpacing the consensus estimate of...
Jul 15, 2025 1:00 PM - Davit Kirakosyan
BNY Mellon Surges After Record Revenue and Strong Earnings Beat
Bank of New York Mellon (NYSE:BK) reported second-quarter results that topped expectations, fueled by broad-based revenue growth and record levels of client assets. The financial services firm posted adjusted earnings of $1.94 per share, well ahead of the $1.75 consensus. Revenue climbed 9% year-ove...
Jul 15, 2025 12:56 PM - Davit Kirakosyan
BlackRock Posts Earnings and AUM Beat, Despite Weaker Inflows
BlackRock (NYSE:BLK) posted second-quarter results that exceeded expectations for earnings, revenue, and assets under management (AUM), despite weaker-than-anticipated net inflows. The company reported earnings per share of $12.05, comfortably surpassing the consensus estimate of $10.60. Revenue cli...
Jul 15, 2025 12:54 PM - Davit Kirakosyan
Citigroup Beats Earnings Expectations, Shares Rise 3%
Citigroup (NYSE:C) reported second-quarter results that outpaced Wall Street forecasts, driven by a sharp rise in trading revenue and a rebound in dealmaking, sending a strong signal that its business transformation is gaining traction. As a result, the company’s shares rose more than 3% intra-day t...
Jul 15, 2025 12:49 PM - Davit Kirakosyan
UBS Downgrades Oscar Health to Sell as Exchange Risks Mount
UBS downgraded Oscar Health (NYSE:OSCR) from Neutral to Sell, cutting its price target to $11 from $15 due to rising concerns over the stability of the Public Health Insurance Exchanges and the company’s exposure to enrollment declines. UBS now expects Oscar’s exchange enrollment to drop by at least...
Jul 15, 2025 12:43 PM - Davit Kirakosyan
Morgan Stanley Upgrades Solventum to Overweight, Sees Significant Upside on Margin Expansion and Growth
Morgan Stanley upgraded Solventum Corporation (NYSE:SOLV) from Equalweight to Overweight, setting a new price target of $103, as the firm sees underappreciated upside in the company’s margin potential and earnings trajectory. The upgrade reflects growing confidence in Solventum’s ability to streamli...
Jul 15, 2025 11:06 AM - Rayan Ahmad
EQT Corporation (NYSE:EQT) Overview and Analyst Rating
EQT Corporation (NYSE:EQT) is a leading natural gas production company in the United States. It focuses on the exploration and production of natural gas, primarily in the Appalachian Basin. As a major player in the energy sector, EQT competes with other energy giants like ExxonMobil and Chevron. The...
